Madrigal Pharmaceuticals, Inc. (LON:0JXI)
301.62
-5.26 (-1.71%)
At close: Aug 1, 2025
Theseus Pharmaceuticals Market Cap
Madrigal Pharmaceuticals has a market cap or net worth of 5.07 billion as of August 1, 2025. Its market cap has increased by 14.74% in one year.
Market Cap
5.07B
Enterprise Value
4.52B
Revenue
245.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
$301.62
Market Cap Chart
Since July 25, 2016, Madrigal Pharmaceuticals's market cap has increased from 87.68M to 5.07B, an increase of 5,676.78%. That is a compound annual growth rate of 56.75%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 5.07B | -5.78% |
Dec 31, 2024 | 5.38B | 49.90% |
Dec 29, 2023 | 3.59B | -16.56% |
Dec 30, 2022 | 4.30B | 301.70% |
Dec 31, 2021 | 1.07B | -15.04% |
Dec 31, 2020 | 1.26B | 18.65% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Jul 25, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 175.60B |
Shell | 159.31B |
HSBC Holdings | 159.21B |
Unilever | 109.82B |
Rolls-Royce Holdings | 89.38B |
British American Tobacco p.l.c. | 88.30B |
Rio Tinto Group | 76.37B |
RELX PLC | 71.14B |